Insys Shareholders Ink Deal With Ex-CEO Over Fraud Claims
A proposed shareholder class announced a settlement with Insys Therapeutics' former CEO in Arizona federal court Tuesday, which would resolve securities fraud claims over the company's alleged kickbacks to doctors who...To view the full article, register now.
Already a subscriber? Click here to view full article